Asia-Pacific Gene Therapy Market Research Report: Type (In Vivo, Ex Vivo), Vector Type (Adenovirus, Non-Viral, Herpes, Simplex Virus), Application (Carcinoma, Nasopharyngeal, Cancer, Acute Lymphoblastic Leukemia, Critical Limb Ischemia, Melanoma), End User (Pharmaceutical and Biotechnology Companies, Academic Institutes and Research Centers) - Industry Analysis and Demand Forecast to 2030

Chapter1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Country

1.3.2 Analysis Period

1.3.3 Market Data Reporting Unit

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents by Country

2.2.2 Breakdown of Primary Research by Industry Participant

2.2.3 Breakdown of Primary Research by Company Type

2.3 Baseline Methodology

2.4 Market Size Estimation

2.5 KOL Sources

2.6 Data Triangulation

2.7 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 In vivo

4.1.1.2 Ex vivo

4.1.2 By Vector Type

4.1.2.1 Adenovirus

4.1.2.2 Lentivirus

4.1.2.3 Non-viral

4.1.2.4 HSV

4.1.3 By Application

4.1.3.1 Carcinoma

4.1.3.2 Nasopharyngeal cancer

4.1.3.3 ALL

4.1.3.4 Critical limb ischemia

4.1.4 By End User

4.1.4.1 Pharmaceutical and biotechnology companies

4.1.4.2 Academic institutes and research centers

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Product launches and grants

4.2.1.2 Outsourcing of vector and gene therapy manufacturing

4.2.2 Drivers

4.2.2.1 Positive clinical results

4.2.2.2 Increasing therapy development activities

4.2.2.3 Surging burden of chronic diseases

4.2.2.4 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Cost-ineffectiveness of gene therapies

4.2.3.2 Long-term safety issues

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Advancements in gene therapies and gene therapy manufacturing process

4.3 Impact of COVID-19

4.4 Porter’s Five Forces Analysis

Chapter 5. APAC Market Size and Forecast

5.1 By Type

5.2 By Vector Type

5.3 By Application

5.4 By End User

5.5 By Country

Chapter 6. China Market Size and Forecast

6.1 By Type

6.2 By Vector Type

6.3 By Application

6.4 By End User

Chapter 7. Japan Market Size and Forecast

7.1 By Type

7.2 By Vector Type

7.3 By Application

7.4 By End User

Chapter 8. Australia Market Size and Forecast

8.1 By Type

8.2 By Vector Type

8.3 By Application

8.4 By End User

Chapter 9. Competitive Landscape

9.1 Market Share Analysis of Key Players

9.2 Impact of Approved Gene Therapy

9.3 Strategical Developments of Key Players

9.3.1 Product Approval/Launch

9.3.2 Others

9.4 List of Major Pipeline and Approved Gene Therapies

9.5 List of Major Gene Therapy Societies

9.6 List of Companies

9.7 Gene Editing Regulations in Major Countries

Chapter 10. Company Profiles

10.1 Sibiono GeneTech Co. Ltd.

10.1.1 Business Overview

10.1.2 Product and Service Offerings

10.2 Shanghai Sunway Biotech Co. Ltd.

10.2.1 Business Overview

10.2.2 Product and Service Offerings

10.3 Kolon Life Science Inc.

10.3.1 Business Overview

10.3.2 Product and Service Offerings

10.4 Novartis AG

10.4.1 Business Overview

10.4.2 Product and Service Offerings

10.4.3 Key Financial Summary

10.5 AnGes Inc.

10.5.1 Business Overview

10.5.2 Product and Service Offerings

10.6. Amgen Inc.

10.6.1. Business Overview

10.6.2. Product and Service Offerings

10.6.3. Key Financial Summary

Chapter 11. Appendix

11.1 Abbreviations

11.2 Sources and References

11.3 Related Reports

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 Drivers for The Market: Impact Analysis

TABLE 3 Restraints for The Market: Impact Analysis

TABLE 4 APAC Gene Therapy MARKET, BY Type, $m (2019–2024)

TABLE 5 APAC Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 6 APAC Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 7 APAC Gene therapy Market, by vector type, $M (2019–2024)

TABLE 8 APAC Gene therapy Market, by vector type, $M (2025–2030)

TABLE 9 APAC Gene therapy Market, by vector type, $M (2025–2030)

TABLE 10 APAC Gene therapy Market, by Application, $M (2019–2024)

TABLE 11 APAC Gene therapy Market, by Application, $M (2025–2030)

TABLE 12 APAC Gene therapy Market, by Application, $M (2025–2030)

TABLE 13 APAC Gene therapy Market, by end user, $M (2019–2024)

TABLE 14 APAC Gene therapy Market, by end user, $M (2025–2030)

TABLE 15 APAC Gene therapy Market, by end user, $M (2025–2030)

TABLE 16 APAC Gene Therapy Market, BY Country, $M (2019–2024)

TABLE 17 APAC Gene Therapy Market, BY country, $M (2025–2030)

TABLE 18 APAC Gene Therapy Market, BY country, $M (2025–2030)

TABLE 19 CHINA Gene Therapy MARKET, BY Type, $m (2019–2024)

TABLE 20 CHINA Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 21 CHINA Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 22 CHINA Gene therapy Market, by vector type, $M (2019–2024)

TABLE 23 CHINA Gene therapy Market, by vector type, $M (2025–2030)

TABLE 24 CHINA Gene therapy Market, by vector type, $M (2025–2030)

TABLE 25 CHINA Gene therapy Market, by Application, $M (2019–2024)

TABLE 26 CHINA Gene therapy Market, by Application, $M (2025–2030)

TABLE 27 CHINA Gene therapy Market, by Application, $M (2025–2030)

TABLE 28 china Gene therapy Market, by end user, $M (2019–2024)

TABLE 29 china Gene therapy Market, by end user, $M (2025–2030)

TABLE 30 china Gene therapy Market, by end user, $M (2025–2030)

TABLE 31 japan Gene Therapy MARKET, BY Type, $m (2019–2024)

TABLE 32 japan Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 33 japan Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 34 japan Gene therapy Market, by vector type, $M (2019–2024)

TABLE 35 japan Gene therapy Market, by vector type, $M (2025–2030)

TABLE 36 japan Gene therapy Market, by vector type, $M (2025–2030)

TABLE 37 japan Gene therapy Market, by Application, $M (2019–2024)

TABLE 38 japan Gene therapy Market, by Application, $M (2025–2030)

TABLE 39 japan Gene therapy Market, by Application, $M (2025–2030)

TABLE 40 japan Gene therapy Market, by end user, $M (2019–2024)

TABLE 41 japan Gene therapy Market, by end user, $M (2025–2030)

TABLE 42 japan Gene therapy Market, by end user, $M (2025–2030)

TABLE 43 australia Gene Therapy MARKET, BY Type, $m (2019–2024)

TABLE 44 australia Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 45 australia Gene Therapy MARKET, BY Type, $M (2025–2030)

TABLE 46 australia Gene therapy Market, by vector type, $M (2019–2024)

TABLE 47 australia Gene therapy Market, by vector type, $M (2025–2030)

TABLE 48 australia Gene therapy Market, by vector type, $M (2025–2030)

TABLE 49 australia Gene therapy Market, by Application, $M (2019–2024)

TABLE 50 australia Gene therapy Market, by Application, $M (2025–2030)

TABLE 51 australia Gene therapy Market, by Application, $M (2025–2030)

TABLE 52 australia Gene therapy Market, by end user, $M (2019–2024)

TABLE 53 australia Gene therapy Market, by end user, $M (2025–2030)

TABLE 54 australia Gene therapy Market, by end user, $M (2025–2030)

TABLE 55 impact of approved gene therapy on apac market

TABLE 56 Gene Editing regulations in major Countries

TABLE 57 Sibiono GeneTech Co. Ltd. – AT a Glance

TABLE 58 Shanghai Sunway Biotech Co. Ltd. – AT a Glance

TABLE 59 Kolon Life Science Inc. – AT a Glance

TABLE 60 novartis ag – At a Glance

TABLE 61 Novartis AG – Key financial Summary

TABLE 62 AnGes Inc.– AT a Glance

TABLE 63 amgen inc. – At a Glance

TABLE 64 amgen inc. – key financial summary

 

List of Figures

 

FIG 1 Research Scope

FIG 2 RESEARCH methodology

FIG 3 breakdown of primary research by Country

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY industry partcipant

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY company type

FIG 6 data triangulation approach

FIG 7 APAC Gene Therapy market summary

FIG 8 bargaining power of buyers

FIG 9 bargaining power of suppliers

FIG 10 intensity of rivalry

FIG 11 Threat of new entrants

FIG 12 Threat of substitutes

FIG 13 APAC Gene Therapy Market snapshot

FIG 14 APAC Gene Therapy MARKET, BY Type, $M (2025–2030)

FIG 15 APAC Gene therapy Market, by vector type, $M (2025–2030)

FIG 16 APAC Gene Therapy Market, by Application, $M (2025–2030)

FIG 17 APAC Gene Therapy Market, by End user, $M (2025–2030)

FIG 18 APAC Gene Therapy Market, by country, $M (2025–2030)

FIG 19 China Gene Therapy Market snapshot

FIG 20 CHINA Gene Therapy MARKET, BY Type, $M (2025–2030)

FIG 21 CHINA Gene therapy Market, by vector type, $M (2025–2030)

FIG 22 CHINA Gene Therapy Market, by Application, $M (2025–2030)

FIG 23 china Gene Therapy Market, by End user, $M (2025–2030)

FIG 24 Japan Gene Therapy Market snapshot

FIG 25 japan Gene Therapy MARKET, BY Type, $M (2025–2030)

FIG 26 japan Gene therapy Market, by vector type, $M (2025–2030)

FIG 27 japan Gene Therapy Market, by Application, $M (2025–2030)

FIG 28 japan Gene Therapy Market, by End user, $M (2025–2030)

FIG 29 Australia Gene Therapy Market snapshot

FIG 30 australia Gene Therapy MARKET, BY Type, $M (2025–2030)

FIG 31 australia Gene therapy Market, by vector type, $M (2025–2030)

FIG 32 australia Gene Therapy Market, by Application, $M (2025–2030)

FIG 33 australia Gene Therapy Market, by End user, $M (2025–2030)

FIG 46 APAC gene therapy market share of key players (2023)

FIG 47 Novartis AG – Revenue split by segment and Geography (2023)

FIG 48 amgen inc.– Revenue split by product and geography (2023)